By: 23 October 2019
JRI Orthopaedics celebrates gold standard rating for shoulder replacement system

JRI Orthopaedics’s shoulder replacement system has been awarded a top five-year rating by ODEP – the Orthopaedic Data Evaluation Panel – in recognition of its clinical performance.

JRI now joins an elite group of just six companies who have an uncemented reverse shoulder with an ODEP rating of 5A or higher.

VAIOS was designed in collaboration with Nottingham City Hospital and The School of Mechanical and Systems Engineering at Newcastle University, famously known for the Newcastle Shoulder Model. After its launch, it won best new mechanical product at the British Engineering Excellence Awards.

The modular system is intended to address key challenges in shoulder replacement surgery to help improve success rates and made the job of the surgical team easier by reducing the number of component parts and instruments.

Product manager, Adam Driver said: “Where VAIOS is different is that it was designed from its conception as a platform system meaning there has been no compromise.

“I think VAIOS demonstrates the best of British design, engineering and manufacturing and shows what can be achieved by a company working with leading academic and clinical partners to deliver effective solutions to improve outcomes for patients requiring shoulder replacement surgery.

“We are very proud to report that, to date, not a single VAIOS uncemented reverse has had to be revised for implant loosening or dislocation – the cause of just over half of shoulder revisions.”

Adam added: “We are, and have always been, a solutions-based company. We know it is important to reproduce the proximal humeral anatomy when performing a prosthetic shoulder replacement.

“This can be difficult with a long-stemmed prosthesis, so we are designing a short stem aimed at overcoming this problem.”

ODEP independently assess whether total hip, knee and shoulder replacement products have reached quality performance benchmarks in accordance with the National Institute for Health and Care Excellence (NICE) guidelines awarding ratings for clinical evidence at three, five, 10 and 13 years.